I-Mab Biopharma is Drug Discovery in China that focus on I-MAB Biopharma business. Founded in 2016. They cover business area such as I-MAB Biopharma, China, Nasdaq, January, its first commercial drug, felzartamab, multiple myeloma, core asset, lemzoparlimab, class, uliledlimab, efineptakin alfa, tumor, treatment-associate lymphopenia.
2016
( 8 years old in 2024 )
I-MAB Biopharma
-
Room 802, West Tower, Haowei Technology Park
88 Shangke Road
Shanghai, 201210
China
Private
I-MAB BiopharmaChinaNasdaqJanuaryits first commercial drugfelzartamabmultiple myelomacore assetlemzoparlimabclassuliledlimabefineptakin alfatumortreatment-associate lymphopenia
* We use standard office opening hours in near I-Mab Biopharma's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
I-Mab Biopharma is Drug Discovery business from China that founded in 2016 (8 years old in 2024), I-Mab Biopharma business is focusing on I-MAB Biopharma.
I-Mab Biopharma headquarter office and corporate office address is located in Room 802, West Tower, Haowei Technology Park 88 Shangke Road Shanghai, 201210 China.
I-Mab Biopharma was founded in China.
In 2024, I-Mab Biopharma is currently focus on I-MAB Biopharma sector.
Above is snippet of Google Trends for "I-MAB Biopharma" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with I-Mab Biopharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
